Category: Pharmaceuticals
Pharmaceuticals market research reports by Roots Analysis
-
SARM1 Targeting Therapeutics Market, 2022-2040
SARM1 Targeting Therapeutics Market, 2022-2040 Neurological disorders are considered the second leading cause of death and the primary cause of long-term disability, worldwide. Across the globe, over 6.5 million neurological disorder related deaths are reported annually. Further, according to a re ... Read More
-
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035
Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogethe ... Read More
-
Bacteriophage Therapeutics Market, 2022-2035
Bacteriophage Therapeutics Market, 2022-2035 Antimicrobial resistance (AMR) has been identified as one of the greatest threats to public health. According to the Centers of Disease Control and Prevention, more than 2.8 million cases of AMR infections are identified in the United States on an annual ... Read More
-
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape More than 10,000 unique species of microorganisms make up the human microbiome; in fact, the total number of microbial cells in the human body is known to vastly outnumber the indigenous cellular population. Of late, many studi ... Read More
-
Rare Kidney Disorders Market, 2022-2035
Rare Kidney Disorders Market, 2022-2035 The term rare kidney diseases represents around 150 different indications. It is worth highlighting that the prevalence rate of rare kidney disorders (RKD) is estimated to be 60-80 per 100,000 cases / individuals in the US and Europe. Despite their relatively ... Read More
-
NAMPT Inhibitors Market, 2022-2040
NAMPT Inhibitors Market, 2022-2040 Globally, cancer is one of the leading causes of death; in 2020, about 10 million cancer related deaths were reported. Further, according to a study published in American Cancer Society Journal, by 2040, the number of cancer cases is projected to reach over 28 mil ... Read More
-
Mini Bioreactors and Micro Bioreactors Market, 2022-2035
Mini Bioreactors and Micro Bioreactors Market, 2022-2035 With several blockbuster therapies (such as Humira®, Rituxan®, Lantus®, Avastin®, Herceptin® and Remicade®) and a robust pipeline of product / therapy candidates, the biopharmaceutical market is anticipated to witness significant growth in the ... Read More
-
Taste Masking and Taste Assessment Services and Technologies Market, 2022-2035
Taste Masking and Taste Assessment Services and Technologies Market, 2022-2035 The oral solid dosage (OSD) market is the largest segment in the pharmaceutical industry, anticipated to reach over USD 900 billion by 2027. However, one of key concerns associated with this industry is that the active ph ... Read More
-
Anti-Aging Therapeutics Market, 2022-2040
Anti-Aging Therapeutics Market, 2022-2040 The advancements in health care and available technologies have inadvertently led to an increase in the life expectancy of individuals. However, this has also led to a rise in the aging population worldwide. According to the United Nations, the aforementione ... Read More
-
Cell Invasion and Migration Assays Market, 2022-2035
Cell Invasion and Migration Assays Market, 2022-2035 According to the World Health Organization (WHO), cancer is the second leading causes of mortality worldwide. In this context, it is important to highlight that around 10 million cancer deaths are reported globally each year. Further, it is estima ... Read More
-
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035 INTRODUCTION RNAi therapeutics have garnered significant attention post the 2006 Nobel Prize that was awarded to Andrew Fire and Craig Mello for the discovery of RNA interference (RNAi). Su ... Read More
-
Metabolomics Services Market, 2022-2035
Since the initiation of the Human Metabolome Project in 2005, the metabolomics technique has gathered significant attention from the industry stakeholders. It is worth mentioning that about 40,000 small molecules constitute the human metabolome. Further, 30% of the known genetic disorders are associ ... Read More
-
Women’s Digital Health Market, 2022-2035
Women’s Digital Health Market, 2022-2035 1.1. SCOPE OF THE REPORT Over the past few years, there have been several advancements in the field of digital health; this has led to an increase in the adoption of digital healthcare solutions. Specifically, the outbreak of COVID-19 pandemic prompted people ... Read More
-
Aptamers: Therapeutics, Technologies, and Services Market, 2022-2035
Aptamers: Therapeutics, Technologies, and Services Market, 2022-2035 Post the approval of the first aptamer-based therapy, Macugen®, by the US Food and Drug Administration (USFDA) in December 2004, there has been a significant increase in the R&D initiatives focused on evaluating the potential o ... Read More
-
Novel Cardiovascular Drug Delivery Devices Market, 2022-2035
Novel Cardiovascular Drug Delivery Devices Market, 2022-2035 Cardiovascular diseases (CVD) are reported to be one of the leading causes of deaths across the globe, surpassing conditions, such as cancer and respiratory disorders. According to the WHO, around one third of the annual global deaths (an ... Read More
-
Vaccine Adjuvant Market (2nd Edition), 2022-2035
Vaccine Adjuvant Market (2nd Edition), 2022-2035 As per recent estimates (reported in May 2022), more than 11.6 billion doses of COVID-19 vaccines have been administered across 184 countries; this value roughly translates to 20.9 million doses per day. Vaccines have enabled the prevention of more t ... Read More
-
Viral Vaccine Cell Culture Media Market, 2022-2035
Viral Vaccine Cell Culture Media Market, 2022-2035 Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fac ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More
-
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for No ... Read More
-
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific)
Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific) 1. It is a well-known fact that c ... Read More
Research Assistance
